Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Wegener's Granulomatosis
NCT00001901Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 1999
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in granulomatosis with polyangiitis (GPA), sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 1999; status: completed.
02
Drugs
etanercept
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT00001901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001901.